New $8.50 price target as of Aug 3/ 2016
https://www.thelifesciencesreport.com/pub/na/resverlogix-seeks-orphan-status-for-lead-drug-candidate
Hopefully we hear of somethng positive from a needed Vote for the cancelled AGM that gets us to that target price........